Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 15, 1989International Journal of Cancer

Relationship between clinical stage, histopathology and antibody titers against the second epstein‐barr virus nuclear antigen (EBNA‐2) in non‐Hodgkin's lymphoma patients

View Full Paper
Ask AI
Bookmark
Share

Authors

GMGiuseppe MasucciKarolinska University HospitalHMHåkan MellstedtKarolinska University HospitalGHGertrude HenleChildren's Hospital of Philadelphia

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Masucci et al. (1989) studied this question.

synapsesocial.com/papers/6a915b2e1fac8a9c65dd4647https://doi.org/10.1002/ijc.2910430610
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Epstein‐Barr virus‐associated antibody pattern in untreated non‐Hodgkin lymphoma patients. Relationship to clinical variables and lymphocyte functions1983 · 8 citations
  2. 2Antibodies to Epstein-Barr Virus-Associated Nuclear Antigen in Infectious Mononucleosis1974 · 178 citations
  3. 3Expression of Epstein‐Barr virus‐encoded proteins in nasopharyngeal carcinoma1988 · 442 citations
  4. 4Expression of a second Epstein-Barr virus-determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genome.1985 · 41 citations